A Trial Monitoring Therapy Pathways of Asthma Patients Treated With an Extrafine ICS/LABA/LAMA Single-inhaler Triple Therapy in a Real-world Setting and Characterizing the Effects on Health-related Out-comes

CompletedOBSERVATIONAL
Enrollment

147

Participants

Timeline

Start Date

June 17, 2021

Primary Completion Date

June 14, 2024

Study Completion Date

June 14, 2024

Conditions
Asthma
Interventions
OTHER

Non-interventional

As this is a non-interventional trial, only data obtained within the current routine management of asthma at outpatient respiratory centres or GP centres will be documented.

Trial Locations (1)

DH7 0BD

The Haven Surgery, The Haven, Burnhope,, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Gesellschaft für Therapieforschung mbH

INDUSTRY

lead

Chiesi UK

INDUSTRY